Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis

Journal of Immunological Methods

Volumn 402, Issue 1-2, 2014, Pages 57-70

  Uchida, Kanji ^a,b   Nakata, Koh ^c   Carey, Brenna ^a   Chalk, Claudia ^a   Suzuki, Takuji ^a   Sakagami, Takuro ^a   Koch, Diana E ^a   Stevens, Carrie ^a   Inoue, Yoshikazu ^d   Yamada, Yoshitsugu ^b   Trapnell, Bruce C ^a,e  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Autoantibodies; Autoimmune disease; Diagnosis; Enzyme linked immunosorbent assay; Granulocyte macrophage colony stimulating factor; Pulmonary alveolar proteinosis

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CALIBRATION; CASE CONTROL STUDY; COMPARATIVE STUDY; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; GRANULOCYTE/MACROPHAGE-COLONY STIMULATING FACTOR; HUMAN; IMMUNOLOGY; LIMIT OF DETECTION; LUNG ALVEOLUS PROTEINOSIS; MALE; MCRS; MIDDLE AGED; MONOCLONAL REFERENCE STANDARD; OBSERVER VARIATION; PAP; PCRS; POLYCLONAL REFERENCE STANDARD; PREDICTIVE VALUE; PROTEIN STABILITY; RECEIVER OPERATING CHARACTERISTIC; RECOMBINANT, HUMAN GM-CSF; REPRODUCIBILITY; RHGM-CSF; STANDARD; TEMPERATURE; TIME; VALIDATION STUDY; YOUNG ADULT;

AUTOANTIBODIES; AUTOIMMUNE DISEASE; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE/MACROPHAGE-COLONY STIMULATING FACTOR; MCRS; MONOCLONAL REFERENCE STANDARD; PAP; PCRS; POLYCLONAL REFERENCE STANDARD; PULMONARY ALVEOLAR PROTEINOSIS; RECOMBINANT, HUMAN GM-CSF; RHGM-CSF;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CALIBRATION; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROTEIN STABILITY; PULMONARY ALVEOLAR PROTEINOSIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TEMPERATURE; TIME FACTORS; YOUNG ADULT;

EID: 84889257249     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.11.011     Document Type: Article

References (27)

1. Anonymous Guidance for industry bioanalytical method validation. Guidance Documents, Vol. 2012 2001, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Bethesda.
2. Bendtzen K., Svenson M., Hansen M.B., Busch T., Bercker S., Kaisers U., Uchida K., Beck D.C., Trapnell B.C. GM-CSF autoantibodies in pulmonary alveolar proteinosis. N. Engl. J. Med. 2007, 356:2001.
3. Bonfield T.L., Russell D., Burgess S., Malur A., Kavuru M.S., Thomassen M.J. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am. J. Respir. Cell Mol. Biol. 2002, 27:481.
4. Bonfield T.L., Raychaudhuri B., Malur A., Abraham S., Trapnell B.C., Kavuru M.S., Thomassen M.J. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1132.
5. Han X., Uchida K., Jurickova I., Koch D., Willson T., Samson C., Bonkowski E., Trauernicht A., Kim M.O., Tomer G., Dubinsky M., Plevy S., Kugathsan S., Trapnell B.C., Denson L.A. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology 2009, 136(1261-71):e1.
6. Ikegami M., Ueda T., Hull W., Whitsett J.A., Mulligan R.C., Dranoff G., Jobe A.H. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am. J. Physiol. 1996, 270:L650.
7. Inoue Y., Trapnell B.C., Tazawa R., Arai T., Takada T., Hizawa N., Kasahara Y., Tatsumi K., Hojo M., Ichiwata T., Tanaka N., Yamaguchi E., Eda R., Oishi K., Tsuchihashi Y., Kaneko C., Nukiwa T., Sakatani M., Krischer J.P., Nakata K. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am. J. Respir. Crit. Care Med. 2008, 177:752.
8. Kitamura T., Tanaka N., Watanabe J., Uchida K., Kanegasaki S., Yamada Y., Nakata K. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1999, 190:875.
9. Kitamura T., Uchida K., Tanaka N., Tsuchiya T., Watanabe J., Yamada Y., Hanaoka K., Seymour J.F., Schoch O.D., Doyle I., Inoue Y., Sakatani M., Kudoh S., Azuma A., Nukiwa T., Tomita T., Katagiri M., Fujita A., Kurashima A., Kanegasaki S., Nakata K. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 2000, 162:658.
10. Luisetti M., Rodi G., Perotti C., Campo I., Mariani F., Pozzi E., Trapnell B.C. Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur. Respir. J. 2009, 33:1220.
11. Martinez-Moczygemba M., Doan M.L., Elidemir O., Fan L.L., Cheung S.W., Lei J.T., Moore J.P., Tavana G., Lewis L.R., Zhu Y., Muzny D.M., Gibbs R.A., Huston D.P. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. J. Exp. Med. 2008, 205:2711.
12. Nakata, K., 1999. Anti-GM-CSF Autoantibodies and Reagents Required for Its Evaluation. In: J.P. Office (Ed.) Japan Patent Office, Number 4372904, Japan.
13. Nogee L.M. Genetic basis of children's interstitial lung disease. Pediatr. Allergy Immunol. Pulmonol. 2010, 23:15.
14. Presneill J.J., Nakata K., Inoue Y., Seymour J.F. Pulmonary alveolar proteinosis. Clin. Chest Med. 2004, 25:593. (viii).
15. Sakagami T., Uchida K., Suzuki T., Carey B.C., Wood R.E., Wert S.E., Whitsett J.A., Trapnell B.C., Luisetti M. Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N. Engl. J. Med. 2009, 361:2679.
16. Sakagami T., Beck D., Uchida K., Suzuki T., Carey B.C., Nakata K., Keller G., Wood R.E., Wert S.E., Ikegami M., Whitsett J.A., Luisetti M., Davies S., Krischer J.P., Brody A., Ryckman F., Trapnell B.C. Patient-derived GM-CSF autoantibodies reproduce pulmonary alveolar proteinosis in non-human primates. Am. J. Respir. Crit. Care Med. 2010, 182:49.
17. Schoch O.D., Schanz U., Koller M., Nakata K., Seymour J.F., Russi E.W., Boehler A. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. Thorax 2002, 57:277.
18. Shibata Y., Berclaz P.Y., Chroneos Z.C., Yoshida M., Whitsett J.A., Trapnell B.C. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001, 15:557.
19. Suzuki T., Sakagami T., Rubin B.K., Nogee L.M., Wood R.E., Zimmerman S.L., Smolarek T., Dishop M.K., Wert S.E., Whitsett J.A., Grabowski G., Carey B.C., Stevens C., van der Loo J.C., Trapnell B.C. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J. Exp. Med. 2008, 205:2703.
20. Suzuki T., Sakagami T., Young L.R., Carey B.C., Wood R.E., Luisetti M., Wert S.E., Rubin B.K., Kevill K., Chalk C., Whitsett J.A., Stevens C., Nogee L.M., Campo I., Trapnell B.C. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am. J. Respir. Crit. Care Med. 2010, 182:1292.
21. Suzuki T., Maranda B., Sakagami T., Catellier P., Couture C., Carey B., Chalk C., Trapnell B. Hereditary pulmonary alveolar proteinosis caused by CSF2RB mutations. Eur. Respir. J. 2011, 37:201.
22. Tanaka T., Motoi N., Tsuchihashi Y., Tazawa R., Kaneko C., Nei T., Yamamoto T., Hayashi T., Tagawa T., Nagayasu T., Kuribayashi F., Ariyoshi K., Nakata K., Morimoto K. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J. Med. Genet. 2011, 48:205.
23. Trapnell B.C., Whitsett J.A., Nakata K. Pulmonary alveolar proteinosis. N. Engl. J. Med. 2003, 349:2527.
24. Uchida K., Nakata K., Trapnell B.C., Terakawa T., Hamano E., Mikami A., Matsushita I., Seymour J.F., Oh-Eda M., Ishige I., Eishi Y., Kitamura T., Yamada Y., Hanaoka K., Keicho N. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004, 103:1089.
25. Uchida K., Beck D.C., Yamamoto T., Berclaz P.Y., Abe S., Staudt M.K., Carey B.C., Filippi M.D., Wert S.E., Denson L.A., Puchalski J.T., Hauck D.M., Trapnell B.C. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N. Engl. J. Med. 2007, 356:567.
26. Uchida K., Nakata K., Suzuki T., Luisetti M., Watanabe M., Koch D.E., Stevens C.A., Beck D.C., Denson L.A., Carey B.C., Keicho N., Krischer J.P., Yamada Y., Trapnell B.C. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 2009, 113:2547.
27. Urlaub G., Kas E., Carothers A.M., Chasin L.A. Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 1983, 33:405.